“Pharma Brothers” Apply to Be Out of Prison for New Crown Drug Research and Development, Court Rejects

A U.S. federal judge has denied a request by jailed former pharmaceutical company executive Martin Shkreli to release him to work on coronavirus treatment,media reported. The disgraced former “pharma brother” is understood to have been sentenced to seven years in prison for securities fraud.

Martin Shkreli Infographic

U.S. District Judge Kiyo Matsumoto said probation officials considered Shkreli’s request a “paranoid act of self-exaggeration” that led to his conviction because by far the world’s best medical and scientific minds had failed to find a cure for the new coronavirus.

Shkreli applied for three months of release and went to an apartment in New York City so he could help with the research. However, the judge said he did not meet the criteria for transferring vulnerable inmates during the New Coronary pandemic — his prison had no new cases of coronary pneumonia reported, and New York City was at the center of the outbreak.

“The court held that the release of Shkreli would not protect the public,” Matsumoto wrote in the judgment. “

In 2015, Shkreli gained notoriety for raising the price of Turing Pharmaceuticals’ AIDS drug Daraprim by 5,000 percent — to $750 a piece. Two years later, he was found to be deceiving investors in his hedge fund.